Literature DB >> 1685446

Functional in vitro assays for the isolation of cell transformation effector and suppressor genes.

H Zarbl1, C J Kho, M O Boylan, J Van Amsterdam, R C Sullivan, C D Hoemann, V L Afshani.   

Abstract

Malignant transformation may be viewed as an imbalance between signals inducing cell growth and signals leading to growth inhibition, differentiation, or senescence. A basic understanding of how these counterbalancing forces interact to regulate normal cell growth is the prerequisite to comprehending the mechanisms of tumorigenesis. Identification and characterization of the gene products implicated in these regulatory pathways is the first step toward understanding the disease process. The studies outlined here provide the potential basis for isolating and molecularly characterizing transformation effector and suppressor genes, which must respectively function in the positive and negative regulation of normal cell growth. The general strategy used involves the isolation and molecular characterization of nontransformed variants (revertants) from populations of tumor cells. The selection of revertants is facilitated by the ability to separate normal from transformed cells by fluorescence-activated sorting. The basis for this separation is the differential retention of the fluorescent dye rhodamine 123 in the mitochondria of normal versus transformed cells. Using this approach, we have isolated revertants from a mutagenized population of v-fos-transformed Rat-1 fibroblasts. Characterization of these clones indicated that they had sustained causal mutations in transformation effector genes. The unmutated effector genes are being identified and molecularly cloned by isolating retransformed clones from revertant cell lines that have been transfected with DNA or cDNA from normal primary cells. The same selection protocol has also been used to isolate revertants from tumor cell lines that have been transfected with DNA or cDNA from primary cells. The putative tumor-suppressor genes present in these revertants are currently being analyzed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685446      PMCID: PMC1568065          DOI: 10.1289/ehp.919383

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  64 in total

1.  Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.

Authors:  S L Naylor; B E Johnson; J D Minna; A Y Sakaguchi
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

2.  A frameshift at a mutational hotspot in the polyoma virus early region generates two new proteins that define T-antigen functional domains.

Authors:  J B Wilson; A Hayday; S Courtneidge; M Fried
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

3.  Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression.

Authors:  B E Weissman; P J Saxon; S R Pasquale; G R Jones; A G Geiser; E J Stanbridge
Journal:  Science       Date:  1987-04-10       Impact factor: 47.728

4.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

Authors:  M Noda; H Kitayama; T Matsuzaki; Y Sugimoto; H Okayama; R H Bassin; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

5.  Malignancy of somatic cell hybrids.

Authors:  B Ephrussi; R L Davidson; M C Weiss; H Harris; G Klein
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

6.  Isolation of a simian virus 40 T-antigen-positive, transformation-resistant cell line by indirect selection.

Authors:  K W Ryan; J B Christensen; M J Imperiale; W W Brockman
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

7.  Marker chromosome stability associated with neoplastic transformation of human uroepithelial cells.

Authors:  S Q Wu; B J Christian; C A Reznikoff; L F Meisner
Journal:  Cancer Genet Cytogenet       Date:  1988-11

8.  Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung.

Authors:  J Yokota; T Akiyama; Y K Fung; W F Benedict; Y Namba; M Hanaoka; M Wada; T Terasaki; Y Shimosato; T Sugimura
Journal:  Oncogene       Date:  1988-10       Impact factor: 9.867

9.  Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

Authors:  J W Harbour; S L Lai; J Whang-Peng; A F Gazdar; J D Minna; F J Kaye
Journal:  Science       Date:  1988-07-15       Impact factor: 47.728

Review 10.  Recessive mechanisms of malignancy.

Authors:  A R Green
Journal:  Br J Cancer       Date:  1988-08       Impact factor: 7.640

View more
  1 in total

1.  Skeletal muscle phenotypically converts and selectively inhibits metastatic cells in mice.

Authors:  Ara Parlakian; Iman Gomaa; Sounkary Solly; Ludovic Arandel; Alka Mahale; Gustav Born; Giovanna Marazzi; David Sassoon
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.